24.12.2020   
EN
Official Journal of the European Union
CI 447/1
Summary of European Union decisions on marketing authorisations in respect of medicinal products from 21 December 2020 to 21 December 2020

         

            
(Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council
 
1
)

      
(2020/C 447 I/01)
—

                     
Issuing of a marketing authorization
 (Article 13 of Regulation (EC) No 726/2004 of the European Parliament and of the Council): 
Accepted

                  
Date of the decision
Name of the medicinal product
INN (International Non-Proprietary Name)
Holder of the marketing authorization
Number of the entry in the Community Register
Pharmaceutical form
ATC code (Anatomical Therapeutic Chemical Code)
Date of notification
21.12.2020
Comirnaty
COVID-19 mRNA Vaccine (nucleoside modified)
BioNTech Manufacturing GmbH An der Goldgrube 12, 55131 Mainz, Deutschland
EU/1/20/1528
Concentrate for dispersion for injection
J07BX
21.12.2020
Anyone wishing to consult the public assessment report on the medicinal products in question and the decisions relating thereto is invited to contact:
European Medicines Agency
Domenico Scarlattilaan 6
1083 HS Amsterdam
NETHERLANDS

         
1
  
.
